{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:44:49Z","timestamp":1768401889215,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10067-017-3600-2","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T03:48:16Z","timestamp":1489376896000},"page":"1445-1451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3038-3482","authenticated-orcid":false,"given":"Michael","family":"Henrickson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"3600_CR1","doi-asserted-by":"publisher","first-page":"5372","DOI":"10.1073\/pnas.1014265108","volume":"108","author":"B Xin","year":"2011","unstructured":"Xin B, Jones S, Puffenberger EG, Hinze C, Bright A, Tan H, Zhou A, Wu G, Vargus-Adams J, Agamanolis D, Wang H (2011) Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke. Proc Natl Acad Sci U S A 108:5372\u20135377. doi:\n10.1073\/pnas.1014265108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3600_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ng.373","volume":"41","author":"GI Rice","year":"2009","unstructured":"Rice GI, Bond J, Asipu A, Brunette RL, Manfield IW, Carr IM, Fuller JC, Jackson RM, Lamb T, Briggs TA, Ali M, Gornall H, Couthard LR, Aeby A, Attard-Montalto SP, Bertini E, Bodemer C, Brockmann K, Brueton LA, Corry PC, Desguerre I, Fazzi E, Cazorla AG, Gener B, Hamel BC, Heiberg A, Hunter M, van der Knaap MS, Kumar R, Lagae L, Landrieu PG, Lourenco CM, Marom D, McDermott MF, van der Merwe W, Orcesi S, Prendiville JS, Rasmussen M, Shalev SA, Soler DM, Shinawi M, Spiegel R, Tan TY, Vanderver A, Wakeling EL, Wassmer E, Whittaker E, Lebon P, Stetson DB, Bonthron DT, Crow YJ (2009) Mutations involved in Aicardi-Gouti\u00e8res syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 41:829\u2013832. doi:\n10.1038\/ng.373","journal-title":"Nat Genet"},{"key":"3600_CR3","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S1474-4422(13)70258-8","volume":"12","author":"GI Rice","year":"2013","unstructured":"Rice GI, Forte GM, Szynkiewicz M, Chase DS, Aeby A, Abdel-Hamid MS, Ackroyd S, Allcock R, Bailey KM, Balottin U, Barnerias C, Bernard G, Bodemer C, Botella MP, Cereda C, Chandler KE, Dabydeen L, Dale RC, De Laet C, De Goede CG, Del Toro M, Effat L, Enamorado NN, Fazzi E, Gener B, Haldre M, Lin JP, Livingston JH, Lourenco CM, Marques W Jr, Oades P, Peterson P, Rasmussen M, Roubertie A, Schmidt JL, Shalev SA, Simon R, Spiegel R, Swoboda KJ, Temtamy SA, Vassallo G, Vilain CN, Vogt J, Wermenbol V, Whitehouse WP, Soler D, Olivieri I, Orcesi S, Aglan MS, Zaki MS, Abdel-Salam GM, Vanderver A, Kisand K, Rozenberg F, Lebon P, Crow YJ (2013) Assessment of interferon-related biomarkers in Aicardi-Gouti\u00e8res syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol 12:1159\u20131169. doi:\n10.1016\/S1474-4422(13)70258-8","journal-title":"Lancet Neurol"},{"key":"3600_CR4","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1093\/hmg\/ddp293","volume":"18","author":"YJ Crow","year":"2009","unstructured":"Crow YJ, Rehwinkel J (2009) Aicardi-Gouti\u00e8res syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 18:R130\u2013R136. doi:\n10.1093\/hmg\/ddp293","journal-title":"Hum Mol Genet"},{"key":"3600_CR5","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/art.27367","volume":"62","author":"G Ramantani","year":"2010","unstructured":"Ramantani G, Kohlhase J, Hertzberg C, Innes AM, Engel K, Hunger S, Borozdin W, Mah JK, Ungerath K, Walkenhorst H, Richardt HH, Buckard J, Bevot A, Siegel C, von St\u00fclpnagel C, Ikonomidou C, Thomas K, Proud V, Niemann F, Wieczorek D, H\u00e4usler M, Niggemann P, Baltaci V, Conrad K, Lebon P, Lee-Kirsch MA (2010) Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Gouti\u00e8res syndrome. Arthritis Rheum 62:1469\u20131477. doi:\n10.1002\/art.27367","journal-title":"Arthritis Rheum"},{"key":"3600_CR6","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/ajmg.a.33359","volume":"152A","author":"RC Dale","year":"2010","unstructured":"Dale RC, Gornall H, Singh-Grewal D, Alcausin M, Rice GI, Crow YJ (2010) Familial Aicardi-Gouti\u00e8res syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures. Am J Med Genet A 152A:938\u2013942. doi:\n10.1002\/ajmg.a.33359","journal-title":"Am J Med Genet A"},{"key":"3600_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1469-8749.2010.03727.x","volume":"52","author":"V Ramesh","year":"2010","unstructured":"Ramesh V, Bernardi B, Stafa A, Garone C, Franzoni E, Abinun M, Mitchell P, Mitra D, Friswell M, Nelson J, Shalev SA, Rice GI, Gornall H, Szynkiewicz M, Aymard F, Ganesan V, Prendiville J, Livingston JH, Crow YJ (2010) Intracerebral large artery disease in Aicardi-Gouti\u00e8res syndrome implicates SAMHD1 in vascular homeostasis. Dev Med Child Neurol 52:725\u2013732. doi:\n10.1111\/j.1469-8749.2010.03727.x","journal-title":"Dev Med Child Neurol"},{"key":"3600_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1086\/513443","volume":"80","author":"G Rice","year":"2007","unstructured":"Rice G, Newman WG, Dean J, Patrick T, Parmar R, Flintoff K, Robins P, Harvey S, Hollis T, O'Hara A, Herrick AL, Bowden AP, Perrino FW, Lindahl T, Barnes DE, Crow YJ (2007) Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Gouti\u00e8res syndrome. Am J Hum Genet 80:811\u2013815. doi:\n10.1086\/513443","journal-title":"Am J Hum Genet"},{"key":"3600_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/ajmg.a.33778","volume":"155A","author":"JC Ravenscroft","year":"2011","unstructured":"Ravenscroft JC, Suri M, Rice GI, Szynkiewicz M, Crow YJ (2011) Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus. Am J Med Genet A 155A:235\u2013237. doi:\n10.1002\/ajmg.a.33778","journal-title":"Am J Med Genet A"},{"key":"3600_CR10","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.4049\/jimmunol.179.7.4711","volume":"179","author":"S Koyama","year":"2007","unstructured":"Koyama S, Ishii KJ, Kumar H, Tanimoto T, Coban C, Uematsu S, Kawai T, Akira S (2007) Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J Immunol 179:4711\u20134720","journal-title":"J Immunol"},{"key":"3600_CR11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","volume":"134","author":"DB Stetson","year":"2008","unstructured":"Stetson DB, Ko JS, Heidmann T, Medzhitov R (2008) Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134:587\u2013598. doi:\n10.1016\/j.cell.2008.06.032","journal-title":"Cell"},{"key":"3600_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature06116","volume":"449","author":"R Lande","year":"2007","unstructured":"Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, Cao W, Wang YH, Su B, Nestle FO, Zal T, Mellman I, Schr\u00f6der JM, Liu YJ, Gilliet M (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449:564\u2013569. doi:\n10.1038\/nature06116","journal-title":"Nature"},{"key":"3600_CR13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.tibs.2003.11.001","volume":"28","author":"CA Kim","year":"2003","unstructured":"Kim CA, Bowie JU (2003) SAM domains: uniform structure, diversity of function. Trends Biochem Sci 28:625\u2013628. doi:\n10.1016\/j.tibs.2003.11.001","journal-title":"Trends Biochem Sci"},{"key":"3600_CR14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0968-0004(98)01293-6","volume":"23","author":"L Aravind","year":"1998","unstructured":"Aravind L, Koonin EV (1998) The HD domain defines a new superfamily of metal-dependent phosphohydrolases. Trends Biochem Sci 23:469\u2013472","journal-title":"Trends Biochem Sci"},{"key":"3600_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nature10623","volume":"480","author":"DC Goldstone","year":"2011","unstructured":"Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF, Yap MW, de Carvalho LP, Stoye JP, Crow YJ, Taylor IA, Webb M (2011) HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480:379\u2013382. doi:\n10.1038\/nature10623","journal-title":"Nature"},{"key":"3600_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ni.2236","volume":"13","author":"H Lahouassa","year":"2011","unstructured":"Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, Pancino G, Priet S, Canard B, Laguette N, Benkirane M, Transy C, Landau NR, Kim B, Margottin-Goguet F (2011) SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 13:223\u2013228. doi:\n10.1038\/ni.2236","journal-title":"Nat Immunol"},{"key":"3600_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/brain\/aws321","volume":"136","author":"E Cuadrado","year":"2013","unstructured":"Cuadrado E, Jansen MH, Anink J, De Filippis L, Vescovi AL, Watts C, Aronica E, Hol EM, Kuijpers TW (2013) Chronic exposure of astrocytes to interferon-\u03b1 reveals molecular changes related to Aicardi-Goutieres syndrome. Brain 136:245\u2013258. doi:\n10.1093\/brain\/aws321","journal-title":"Brain"},{"key":"3600_CR18","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1046\/j.1432-1327.2000.01300.x","volume":"267","author":"JL Harcourt","year":"2000","unstructured":"Harcourt JL, Offermann MK (2000) Interferon-alpha synergistically enhances induction of interleukin-6 by double stranded RNA in HeLa cells. Eur J Biochem 267:2768\u20132777","journal-title":"Eur J Biochem"},{"key":"3600_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ijcard.2012.01.035","volume":"156","author":"Y Sun","year":"2012","unstructured":"Sun Y, Ma L, Yan F, Liu H, Ding Y, Hou J, Jiang L (2012) MMP-9 and IL-6 are potential biomarkers for disease activity in Takayasu\u2019s arteritis. Int J Cardiol 156:236\u2013238. doi:\n10.1016\/j.ijcard.2012.01.035","journal-title":"Int J Cardiol"},{"key":"3600_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/08880018.2013.860648","volume":"32","author":"FS Cayci","year":"2013","unstructured":"Cayci FS, Ekim M, Egin Y, G\u00f6kce H, Yalcinkaya F, Ozcakar B, Akar N (2013) An analysis of the levels of the soluble form of the endothelial protein C receptor in children with Henoch-Sch\u00f6nlein purpura. Pediatr Hematol Oncol 32:115\u2013122. doi:\n10.3109\/08880018.2013.860648","journal-title":"Pediatr Hematol Oncol"},{"key":"3600_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/BOR.0000000000000004","volume":"26","author":"A Clifford","year":"2014","unstructured":"Clifford A, Hoffman GS (2014) Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies. Curr Opin Rheumatol 26:7\u201315. doi:\n10.1097\/BOR.0000000000000004","journal-title":"Curr Opin Rheumatol"},{"key":"3600_CR22","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/rheumatology\/ket320","volume":"53","author":"G Keser","year":"2014","unstructured":"Keser G, Direskeneli H, Aksu K (2014) Management of Takayasu arteritis: a systematic review. Rheumatology (Oxford) 53:793\u2013801. doi:\n10.1093\/rheumatology\/ket320","journal-title":"Rheumatology (Oxford)"},{"key":"3600_CR23","first-page":"476","volume":"39","author":"CY Lin","year":"2006","unstructured":"Lin CY, Yang YH, Lee CC, Huang CL, Wang LC, Chiang BL (2006) Thrombopoietin and interleukin-6 levels in Henoch-Sch\u00f6nlein purpura. J Microbiol Immunol Infect 39:476\u2013482","journal-title":"J Microbiol Immunol Infect"},{"key":"3600_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/rheumatology\/keh058","volume":"43","author":"J Hern\u00e1ndez-Rodr\u00edguez","year":"2004","unstructured":"Hern\u00e1ndez-Rodr\u00edguez J, Segarra M, Vilardell C, S\u00e1nchez M, Garc\u00eda-Mart\u00ednez A, Esteban MJ, Queralt C, Grau JM, Urbano-M\u00e1rquez A, Palac\u00edn A, Colomer D, Cid MC (2004) Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis. Rheumatology (Oxford) 43:294\u2013301. doi:\n10.1093\/rheumatology\/keh058","journal-title":"Rheumatology (Oxford)"},{"key":"3600_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0198-8859(94)90096-5","volume":"39","author":"D Emilie","year":"1994","unstructured":"Emilie D, Liozon E, Crevon MC, Lavignac C, Portier A, Liozon F, Galanaud P (1994) Production of interleukin 6 by granulomas of giant cell arteritis. Hum Immunol 39:17\u201324","journal-title":"Hum Immunol"},{"key":"3600_CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2177\/jsci.36.27","volume":"36","author":"J Abe","year":"2013","unstructured":"Abe J, Matsuda A (2013) Biomarkers associated with unresponsiveness to IVIG in children with Kawasaki disease. Nihon Rinsho Meneki Gakkai Kaishi 36:27\u201334","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"3600_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/sji.12022","volume":"77","author":"X Ge","year":"2013","unstructured":"Ge X, Li CR, Yang J, Wang GB (2013) Aberrantly decreased levels of NKG2D expression in children with Kawasaki disease. Scand J Immunol 77:389\u2013397. doi:\n10.1111\/sji.12022","journal-title":"Scand J Immunol"},{"key":"3600_CR28","doi-asserted-by":"publisher","first-page":"e38635","DOI":"10.1371\/journal.pone.0038635","volume":"7","author":"IC Lin","year":"2012","unstructured":"Lin IC, Kuo HC, Lin YJ, Wang FS, Wang L, Huang SC, Chien SJ, Huang CF, Wang CL, Yu HR, Chen RF, Yang KD (2012) Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis. PLoS One 7:e38635. doi:\n10.1371\/journal.pone.0038635","journal-title":"PLoS One"},{"key":"3600_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/BOR.0b013e32835b133a","volume":"25","author":"S Unizony","year":"2013","unstructured":"Unizony S, Stone JH, Stone JR (2013) New treatment strategies in large-vessel vasculitis. Curr Opin Rheumatol 25:3\u20139. doi:\n10.1097\/BOR.0b013e32835b133a","journal-title":"Curr Opin Rheumatol"},{"key":"3600_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/rheumatology\/ker296","volume":"51","author":"C Salvarani","year":"2012","unstructured":"Salvarani C, Magnani L, Catanoso M, Pipitone N, Versari A, Dardani L, Pulsatelli L, Meliconi R, Boiardi L (2012) Tocilizumab: a novel therapy for patients with large-vessel vasculitis. Rheumatology (Oxford) 51:151\u2013156. doi:\n10.1093\/rheumatology\/ker296","journal-title":"Rheumatology (Oxford)"},{"key":"3600_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/BOR.0b013e32834dc392","volume":"24","author":"VS Sch\u00e4fer","year":"2012","unstructured":"Sch\u00e4fer VS, Zwerina J (2012) Biologic treatment of large-vessel vasculitides. Curr Opin Rheumatol 24:31\u201337. doi:\n10.1097\/BOR.0b013e32834dc392","journal-title":"Curr Opin Rheumatol"},{"key":"3600_CR32","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/acr.21750","volume":"64","author":"S Unizony","year":"2012","unstructured":"Unizony S, Arias-Urdaneta L, Miloslavsky E, Arvikar S, Khosroshahi A, Keroack B, Stone JR, Stone JH (2012) Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica. Arthritis Care Res (Hoboken) 64:1720\u20131729. doi:\n10.1002\/acr.21750","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3600_CR33","doi-asserted-by":"publisher","first-page":"w13156","DOI":"10.4414\/smw.2011.13156","volume":"141","author":"M Seitz","year":"2011","unstructured":"Seitz M, Reichenbach S, Bonel HM, Adler S, Wermelinger F, Villiger PM (2011) Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series. Swiss Med Wkly 141:w13156. doi:\n10.4414\/smw.2011.13156","journal-title":"Swiss Med Wkly"},{"key":"3600_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.clineuro.2011.10.024","volume":"114","author":"LS Shapiro","year":"2012","unstructured":"Shapiro LS, Farrell J, Borhani Haghighi A (2012) Tocilizumab treatment for neuro-Beh\u00e7et\u2019s disease, the first report. Clin Neurol Neurosurg 114:297\u2013298. doi:\n10.1016\/j.clineuro.2011.10.024","journal-title":"Clin Neurol Neurosurg"},{"key":"3600_CR35","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.semarthrit.2014.08.004","volume":"44","author":"O Addimanda","year":"2015","unstructured":"Addimanda O, Pipitone N, Pazzola G, Salvarani C (2015) Tocilizumab for severe refractory neuro-Behcet: three cases IL-6 blockade in neuro-Behcet. Semin Arthritis Rheum 44:472\u2013475. doi:\n10.1016\/j.semarthrit.2014.08.004","journal-title":"Semin Arthritis Rheum"},{"key":"3600_CR36","first-page":"S76","volume":"32","author":"F Oliveira","year":"2014","unstructured":"Oliveira F, Butendieck RR, Ginsburg WW, Parikh K, Abril A (2014) Tocilizumab, an effective treatment for relapsing giant cell arteritis. Clin Exp Rheumatol 32:S76\u2013S78","journal-title":"Clin Exp Rheumatol"},{"key":"3600_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.revmed.2012.12.012","volume":"35","author":"P Kieffer","year":"2014","unstructured":"Kieffer P, Hinschberger O, Ciobanu E, Jaeger-Bizet F, Drabo A, Mostoufizadeh T, Martzolff L (2014) Clinical and biological efficacy of tocilizumab in giant cell arteritis: report of three patients and literature review. Rev Med Interne 35:56\u201359. doi:\n10.1016\/j.revmed.2012.12.012","journal-title":"Rev Med Interne"},{"issue":"3 Suppl 97","key":"3600_CR38","first-page":"S44","volume":"34","author":"J Loricera","year":"2016","unstructured":"Loricera J, Blanco R, Hern\u00e1ndez JL, Casta\u00f1eda S, Humbr\u00eda A, Ortego N, Bravo B, Freire M, Melchor S, M\u00ednguez M, Salvatierra J, Gonz\u00e1lez-Vela C, Calvo-R\u00edo V, Santos-G\u00f3mez M, Pina T, Gonz\u00e1lez-Gay MA (2016) Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review. Clin Exp Rheumatol 34(3 Suppl 97):S44\u2013S53","journal-title":"Clin Exp Rheumatol"},{"key":"3600_CR39","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.autrev.2016.02.012","volume":"15","author":"Y Ferfar","year":"2016","unstructured":"Ferfar Y, Mirault T, Desbois AC, Comarmond C, Messas E, Savey L, Domont F, Cacoub P, Saadoun D (2016) Biotherapies in large vessel vasculitis. Autoimmun Rev 15:544\u2013551. doi:\n10.1016\/j.autrev.2016.02.012","journal-title":"Autoimmun Rev"},{"key":"3600_CR40","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1016\/j.lpm.2015.04.010","volume":"44","author":"G Pazzola","year":"2015","unstructured":"Pazzola G, Muratore F, Pipitone N, Salvarani C (2015) Biologics in vasculitides: where do we stand, where do we go from now? Presse Med 44:e231\u2013e239. doi:\n10.1016\/j.lpm.2015.04.010","journal-title":"Presse Med"},{"key":"3600_CR41","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10067-011-1924-x","volume":"31","author":"WA Sifuentes Giraldo","year":"2012","unstructured":"Sifuentes Giraldo WA, Ahij\u00f3n Lana M, Garc\u00eda Villanueva MJ, Gonz\u00e1lez Garc\u00eda C, V\u00e1zquez Diaz M (2012) Chilblain lupus induced by TNF-\u03b1 antagonists: a case report and literature review. Clin Rheumatol 31:563\u2013568. doi:\n10.1007\/s10067-011-1924-x","journal-title":"Clin Rheumatol"},{"key":"3600_CR42","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/archdermatol.2011.307","volume":"147","author":"MA Judson","year":"2011","unstructured":"Judson MA (2011) Successful treatment of lupus pernio with adalimumab. Arch Dermatol 147:1332\u20131333. doi:\n10.1001\/archdermatol.2011.307","journal-title":"Arch Dermatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3600-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3600-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3600-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T01:07:58Z","timestamp":1496365678000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3600-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["3600"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3600-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]}}}